Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

21.07USD
1:00pm EST
Price Change (% chg)

$-0.77 (-3.53%)
Prev Close
$21.84
Open
$21.88
Day's High
$21.90
Day's Low
$21.02
Volume
189,273
Avg. Vol
1,344,465
52-wk High
$74.57
52-wk Low
$19.10

AEGR.O

Chart for AEGR.O

About

Aegerion Pharmaceuticals, Inc. (Aegerio) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat lipid disorders. As of December 31, 2011, the Company developed its first product candidate, lomitapide, as an oral, once-a-day treatment for patients with a inherited lipid disorder... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $621.04
Shares Outstanding (Mil.): 28.44
Dividend: --
Yield (%): --

Financials

  AEGR.O Industry Sector
P/E (TTM): -- 37.69 38.55
EPS (TTM): -1.54 -- --
ROI: -18.23 17.92 17.25
ROE: -32.65 18.73 18.17
Search Stocks

BRIEF-Astrazeneca sells Myalept to Aegerion

* Entered into a definitive agreement with aegerion pharmaceuticals, inc. To divest myalept (metreleptin for injection), Source text for Eikon: Further company coverage:

06 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks